GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Folic Acid Network

pathways : Folic Acid Network pathways:

Fullview (zoomIn)


Related Pathways to "Folic Acid Network" content :


Related Genes to "Folic Acid Network" content :

preload


Related products :

Catalog number Product name Quantity
B527 *Folic Acid Culture Agar USE For maintenance of Streptococcus faecalis ATCC 8043 used as a test organism in folic acid assay. Qty per Litre of Medium: 48
B527 Folic Acid Culture Agar USE : For maintenance of Streptococcus faecalis ATCC 8043 used as a test organism in folic acid assay. 5x500gm
B528 *Folic Acid Inoculum Medium USE For preparation of inoculum of Streptococcus faecalis ATCC 8043 used as a test organism for folic acid assay. Qty per Litre of Medium: 38
B528 Folic Acid Inoculum Medium USE : For preparation of inoculum of Streptococcus faecalis ATCC 8043 used as a test organism for folic acid assay. 5x500gm
B192 *Folic Acid Medium,AOAC USE Recommended by AOAC for microbiological assay of folic acid using Streptococcus faecium ATCC 8043. Qty per Litre of Medium: 111
B191 Folic Acid Casei Medium USE : For microbiological assay of folic acid in blood serum using Lactobacillus casei ATCC 7469. 5x500gm
B191 *Folic Acid Casei Medium USE For microbiological assay of folic acid in blood serum using Lactobacillus casei ATCC 7469. Qty per Litre of Medium: 94
B192 Folic Acid Medium,AOAC USE : Recommended by AOAC for microbiological assay of folic acid using Streptococcus faecium ATCC 8043. 5x500gm
MCA2870 MOUSE ANTI FOLIC ACID, Product Type Monoclonal Antibody, Specificity FOLIC ACID, Target Species Chemical, Host Mouse, Format Purified, Isotypes IgG2a, Applications E, Clone FA2 0.2 mg
SCH-MCA2870 MOUSE ANTI FOLIC ACID, Product Type Monoclonal Antibody, Specificity FOLIC ACID, Target Species Chemical, Host Mouse, Format Purified, Isotypes IgG2a, Applications E, Clone FA2 0.2 mg
orb61464 Folic acid Folic acid For research use only. 500 g
PG2-CAFA-5k Folic acid PEG acid, FA-PEG-COOH, 5000 Da 50 mg
PG2-CAFA-10k Folic acid PEG acid, FA-PEG-COOH, 10000 Da 50 mg
PG2-CAFA-3k Folic acid PEG acid, FA-PEG-COOH, 3400 Da 50 mg
PG2-CAFA-2k Folic acid PEG acid, FA-PEG-COOH, 2000 Da 50 mg
75708-92-8 Folic acid dihydrat Pteroylglutamic acid 1g
PG2-CAFA-2k Folic acid PEG acid, FA-PEG-COOH 50 mg
PG2-CAFA-3k Folic acid PEG acid, FA-PEG-COOH 50 mg
PG2-CAFA-5k Folic acid PEG acid, FA-PEG-COOH 50 mg
40600064-2 Folic acid [Pteroylglutamic acid] 100 g
40600064-1 Folic acid [Pteroylglutamic acid] 25 g
PG2-CAFA-10k Folic acid PEG acid, FA-PEG-COOH 50 mg
59-30-3 Folic Acid(Vb9) 1 kg
FOL-E01 Folic Acid
E27-395 Folic Acid 96 Tests

Pathways :

WP1311: Folic Acid Network
WP1273: Folic Acid Network
WP1075: Folic Acid Network
WP1192: Folic Acid Network
WP555: Folic acid biosynthesis
WP2102: Fatty acid metabolism
WP674: Tricarboxylic acid cycle
WP1139: Fatty Acid Biosynthesis
WP1647: Fatty acid biosynthesis
WP406: Mitochondrial LC-Fatty Acid Beta-Oxidation
WP991: Hypothetical Network for Drug Addiction
WP472: Phosphatidic Acid and Phospholipid Biosynthesis
WP1352: Fatty Acid Biosynthesis
WP2318: Fatty acid oxidation
WP763: Mitochondrial LC-Fatty Acid Beta-Oxidation
WP1207: Fatty Acid Beta Oxidation
WP1666: Linoleic acid metabolism
WP825: Fatty Acid Beta Oxidation
WP1228: Fatty Acid Biosynthesis
WP1696: Riboflavin metabolism
WP504: Fatty Acid Biosynthesis
WP148: Fatty Acid Beta Oxidation 2
WP2434: very-long-chain-fatty-acid-biosynthesis
WP1020: Fatty Acid Biosynthesis
WP1585: ascorbic acid

Related Genes :
[fol1 fas] Folic acid synthesis protein fol1 [Includes: Dihydroneopterin aldolase (DHNA) (EC 4.1.2.25) (7,8-dihydroneopterin aldolase) (FasA) (FasB); 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase (HPPK) (EC 2.7.6.3) (2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase) (7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase) (PPPK) (Dihydropterin pyrophosphokinase) (FasC); Dihydropteroate synthase (DHPS) (EC 2.5.1.15) (Dihydropteroate pyrophosphorylase) (FasD)]
[FOL1 YNL256W N0848] Folic acid synthesis protein FOL1 [Includes: Dihydroneopterin aldolase (DHNA) (EC 4.1.2.25) (7,8-dihydroneopterin aldolase) (FASA) (FASB); 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase (HPPK) (EC 2.7.6.3) (2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase) (7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase) (PPPK) (FASC); Dihydropteroate synthase (DHPS) (EC 2.5.1.15) (Dihydropteroate pyrophosphorylase) (FASD)]
[fol1 SPBC1734.03 SPBC337.19] Folic acid synthesis protein fol1 [Includes: Dihydroneopterin aldolase (DHNA) (EC 4.1.2.25) (7,8-dihydroneopterin aldolase) (FASA) (FASB); 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase (HPPK) (EC 2.7.6.3) (2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase) (7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase) (PPPK) (FASC); Dihydropteroate synthase (DHPS) (EC 2.5.1.15) (Dihydropteroate pyrophosphorylase) (FASD)]
[fol1 DDB_G0278283] Folic acid synthesis protein FOL1 [Includes: Dihydroneopterin aldolase (DHNA) (EC 4.1.2.25) (7,8-dihydroneopterin aldolase); 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase (HPPK) (2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase) (EC 2.7.6.3) (7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase) (PPPK); Dihydropteroate synthase (DHPS) (EC 2.5.1.15) (Dihydropteroate pyrophosphorylase)]
[FURIN FUR PACE] Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE) (Trans Golgi network protease furin)
[TGOLN2 TGN46 TGN51] Trans-Golgi network integral membrane protein 2 (TGN38 homolog) (TGN46) (TGN48) (Trans-Golgi network protein TGN51)
[AGD3 FKD2 SFC VAN3 At5g13300 T31B5.120] ADP-ribosylation factor GTPase-activating protein AGD3 (ARF GAP AGD3) (Protein ARF-GAP DOMAIN 3) (AtAGD3) (Protein FORKED 2) (Protein SCARFACE) (Protein VASCULAR NETWORK 3)
[cdc11 SPCC1739.11c] Septation initiation network scaffold protein cdc11 (SIN scaffold protein cdc11) (Cell division control protein 11)
[CTF3 CHL3 YLR381W] Inner kinetochore subunit CTF3 (CENP-I homolog) (Chromosome loss protein 3) (Chromosome transmission fidelity protein 3) (Constitutive centromere-associated network protein CTF3)
[NNK1 YKL171W YKL635] Nitrogen network kinase 1 (EC 2.7.11.1)
[CNN1 YFR046C] Inner kinetochore subunit CNN1 (CENP-T homolog) (Co-purified with NNF1 protein 1) (Constitutive centromere-associated network protein CNN1)
[CCN2 CTGF HCS24 IGFBP8] CCN family member 2 (Cellular communication network factor 2) (Connective tissue growth factor) (Hypertrophic chondrocyte-specific protein 24) (Insulin-like growth factor-binding protein 8) (IBP-8) (IGF-binding protein 8) (IGFBP-8)
[Ccn2 betaIG-M2 Ctgf Fisp-12 Fisp12 Hcs24] CCN family member 2 (Cellular communication network factor 2) (Connective tissue growth factor) (Hypertrophic chondrocyte-specific protein 24) (Protein FISP-12)
[Ccn2 Ctgf] CCN family member 2 (Cellular communication network factor 2) (Connective tissue growth factor) (Connective tissue growth-related protein)
[CCN6 WISP3 UNQ462/PRO790/PRO956] Cellular communication network factor 6 (CCN family member 6) (WNT1-inducible-signaling pathway protein 3) (WISP-3)
[MCM21 CTF5 YDR318W] Inner kinetochore subunit MCM21 (CENP-O homolog) (Chromosome transmission fidelity protein 5) (Constitutive centromere-associated network protein MCM21) (Minichromosome maintenance protein 21)
[MIF2 YKL089W] Inner kinetochore subunit MIF2 (CENP-C homolog) (Constitutive centromere-associated network protein MIF2) (Mitotic fidelity of chromosome transmission protein 2)
[mis6 SPAC1687.20c] Inner kinetochore subunit mis6 (CENP-I homolog) (Constitutive centromere-associated network protein mis6) (Sim4 complex subunit mis6)
[AMN1 CST13 ICS4 YBR158W YBR1208] Antagonist of mitotic exit network protein 1 (Chromosome stability protein 13) (Increased copper-sensitivity protein 4)
[CTF19 MCM18 YPL018W LPB13W] Inner kinetochore subunit CTF19 (CENP-P homolog) (Chromosome transmission fidelity protein 19) (Constitutive centromere-associated network protein CTF19) (Minichromosome maintenance protein 18)
[CHL4 CTF17 MCM17 YDR254W YD9320A.04] Inner kinetochore subunit CHL4 (CENP-N homolog) (Chromosome loss protein 4) (Chromosome transmission fidelity protein 17) (Constitutive centromere-associated network protein CHL4) (Minichromosome maintenance protein 17)
[GN EMB30 GBF3 MIZ2 VAN7 At1g13980 F16A14.20 F7A19.7] ARF guanine-nucleotide exchange factor GNOM (Pattern formation protein EMB30) (Protein EMBRYO DEFECTIVE 30) (Protein MIZU-KUSSEI2) (Protein VASCULAR NETWORK 7)
[AME1 ARP100 YBR211C YBR1458] Inner kinetochore subunit AME1 (Associated with microtubules and essential protein 1) (CENP-U homolog) (Constitutive centromere-associated network protein AME1)
[OKP1 YGR179C] Inner kinetochore subunit OKP1 (CENP-Q homolog) (Constitutive centromere-associated network protein OKP1) (Outer kinetochore protein 1)
[Ciart Gm129] Circadian-associated transcriptional repressor (ChIP-derived repressor of network oscillator) (Chrono) (Computationally highlighted repressor of the network oscillator)
[Ttgn1] Trans-Golgi network integral membrane protein TGN38
[cnp3 SPBC1861.01c SPBC56F2.13] Inner kinetochore subunit cnp3 (CENP-C homolog) (Centromere protein 3) (Constitutive centromere-associated network protein cnp3)
[CCN1 CYR61 GIG1 IGFBP10] CCN family member 1 (Cellular communication network factor 1) (Cysteine-rich angiogenic inducer 61) (Insulin-like growth factor-binding protein 10) (IBP-10) (IGF-binding protein 10) (IGFBP-10) (Protein CYR61) (Protein GIG1)
[Ccn1 Cyr61 Igfbp10] CCN family member 1 (3CH61) (Cellular communication network factor 1) (Cysteine-rich angiogenic inducer 61) (Insulin-like growth factor-binding protein 10) (IBP-10) (IGF-binding protein 10) (IGFBP-10) (Protein CYR61)
[CCN1 CYR61] CCN family member 1 (Cellular communication network factor 1) (Protein CEF-10) (Protein CYR61)

Bibliography :
[31408914] In Utero One-Carbon Metabolism Interplay and Metabolic Syndrome in Cardiovascular Disease Risk Reduction.
[31405247] Nanoemulsion Structural Design in Co-Encapsulation of Hybrid Multifunctional Agents: Influence of the Smart PLGA Polymers on the Nanosystem-Enhanced Delivery and Electro-Photodynamic Treatment.
[31392711] Exposure to dolutegravir in pregnant women living with HIV in Central and Eastern Europe and neighboring countries - data from the ECEE Network Group.
[31259167] Fabrication of [email protected] Composite With Enhanced Rate Properties.
[31240835] Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease.
[31066195] Maternal nutrition practices in Uttar Pradesh, India: Role of key influential demand and supply factors.
[31018951] Transcriptome Alterations in Liver Metastases of Colorectal Cancer After Acquired Resistance to Cetuximab.
[31015461] Meta-analysis of epigenome-wide association studies in neonates reveals widespread differential DNA methylation associated with birthweight.
[31010874] Prepregnancy Habitual Intakes of Total, Supplemental, and Food Folate and Risk of Gestational Diabetes Mellitus: A Prospective Cohort Study.
[30987583] Leveraging the effects of chloroquine on resistant malaria parasites for combination therapies.